PillInsulin Lispro
Brands: Admelog · Humalog · Humalog Kwikpen · Insulin Lispro
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Eli Lilly and Company | unknown | 6 | SUPPLYING |
| A-S Medication Solutions | unknown | 5 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 24, 2025RESOLVEDShortage resolved: Insulin Lispro Injection (Eli Lilly and Co.)
Insulin Lispro Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Endocrinology/Metabolism.
- Oct 24, 2025SHORTAGEDrug shortage: Insulin Lispro Injection (Eli Lilly and Co.)
Insulin Lispro Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Endocrinology/Metabolism.
- Apr 11, 2023RECALLRecall (Class II): Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgew…
Lack of Assurance of Sterility: Malformed crimped collar seal — Recalling firm: Sanofi-Aventis U.S. LLC — Nationwide in the USA
- Jul 5, 2018RECALLRecall (Class II): Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per…
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature. — Recalling firm: Sanofi-Aventis U.S. LLC — Nationwide